WuXi AppTec (WUXAY) Expected to Announce Quarterly Earnings on Tuesday

WuXi AppTec (OTCMKTS:WUXAY) is expected to be releasing its resultson Tuesday, April 28th. Analysts expect WuXi AppTec to post earnings of $0.1773 per share and revenue of $1.5930 billion for the quarter.

WuXi AppTec Stock Performance

Shares of WUXAY stock opened at $16.95 on Tuesday. The firm has a fifty day moving average price of $15.03 and a 200 day moving average price of $14.21. WuXi AppTec has a 12 month low of $6.44 and a 12 month high of $17.00.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on WUXAY. The Goldman Sachs Group upgraded shares of WuXi AppTec to a “buy” rating in a research note on Thursday, February 5th. Zacks Research raised shares of WuXi AppTec to a “hold” rating in a research report on Monday, April 13th. One investment analyst has rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy”.

WuXi AppTec Company Profile

WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.

Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.